Mankind Pharma Limited Mankind Pharma Limited

Mankind Pharma Limited

MANKIND

Kedudukan dalam Saham #2054
Mankind Pharma Limited specializes in the development, manufacturing, and... Mankind Pharma Limited specializes in the development, manufacturing, and marketing of a broad range of pharmaceutical medications and consumer health goods. Operating predominantly in India, the company also caters to international markets. Its pharmaceutical division focuses on both acute and chronic therapeutic areas, encompassing a wide spectrum of medical conditions such as infectious diseases, cardiovascular ailments, gastrointestinal disorders, diabetes, dermatology, pain management, neuro/CNS issues, nutritional support (vitamins/minerals), and respiratory problems. Complementing its pharmaceutical portfolio, the consumer healthcare segment offers diverse products, including condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. Key brands under its umbrella include Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar. Furthermore, the company's business activities are diversified, extending to the trading and export of pharmaceutical and healthcare products, as well as the manufacturing of various goods such as packaging materials, ayurvedic products, bulk drugs, and general consumer items. Mankind Pharma also holds interests in real estate, leasing, hospitality, and IT services. Established in 1986, Mankind Pharma Limited maintains its headquarters in New Delhi, India.
Harga Saham
$24.08
Modal Pasaran
$9.95B
Perubahan (1 hari)
-4.09%
Perubahan (1 tahun)
-13.33%
Negara
IN
Perdagangan Mankind Pharma Limited (MANKIND)

Kategori

Healthcare
Margin Operasi untuk Mankind Pharma Limited (MANKIND)
Margin Operasi pada October 2026 TTM: 19.91%
Menurut laporan kewangan dan harga saham terkini Mankind Pharma Limited, margin operasi semasa (TTM) ialah 19.91%. Pada akhir 2025, margin operasi syarikat ialah 20.61%.
Sejarah Margin Operasi untuk Mankind Pharma Limited dari 2019 hingga 2026
Margin Operasi pada akhir setiap tahun
Tahun Margin Operasi Ubah
2026 (TTM) 19.91% -3.40%
2025 20.61% -47.88%
2024 39.54% 113.61%
2023 18.51% -22.62%
2022 23.92% -7.47%
2021 25.85% 0.15%
2020 25.81% 47.82%
2019 17.46% 0.00%
Margin Operasi untuk syarikat serupa atau pesaing
Syarikat Margin Operasi Perbezaan Margin Operasi Negara
19.41% -99.03%
DE
0.00% -
DE
10.52% -99.47%
JP
17.08% -99.14%
CH
22.93% -98.85%
IN
Apakah Margin Operasi sesebuah syarikat?
Margin Operasi ialah penunjuk utama untuk menilai keuntungan sesebuah syarikat. Margin Operasi yang lebih tinggi lazimnya lebih baik kerana menunjukkan bahawa syarikat mampu menjual produk atau perkhidmatannya dengan harga yang jauh lebih tinggi daripada kos pengeluarannya. Ia dikira dengan membahagikan keuntungan syarikat dengan hasilnya.